LUTZ, Fla., April 13, 2012 (GLOBE NEWSWIRE) -- CytoDyn Inc. (the "Company") (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, and other antibody applications, announced today that it has engaged The Trout Group LLC, a leading investor relations and strategic advisory firm.
